Tuberculosis

DR-TB drugs under the microscope

Treating DR-TB is complicated from a programmatic perspective: treatment is individualised, tailored according to which drugs a patient is resistant to. It is long and taxing, requiring people to take a course of antibiotics for up to two years and endure often intolerable side effects.

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines pdf — 632.63 KB Download